MA26558A1 - Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant. - Google Patents
Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.Info
- Publication number
- MA26558A1 MA26558A1 MA25314A MA25314A MA26558A1 MA 26558 A1 MA26558 A1 MA 26558A1 MA 25314 A MA25314 A MA 25314A MA 25314 A MA25314 A MA 25314A MA 26558 A1 MA26558 A1 MA 26558A1
- Authority
- MA
- Morocco
- Prior art keywords
- methylerythromycin
- derivatives
- novel
- preparation
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6367697P | 1997-10-29 | 1997-10-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA26558A1 true MA26558A1 (fr) | 2004-12-20 |
Family
ID=22050768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA25314A MA26558A1 (fr) | 1997-10-29 | 1998-10-26 | Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant. |
Country Status (13)
Country | Link |
---|---|
US (1) | US6159945A (fr) |
AP (1) | AP9801378A0 (fr) |
AR (1) | AR017177A1 (fr) |
AU (1) | AU9277698A (fr) |
CO (1) | CO4810375A1 (fr) |
GT (1) | GT199800163A (fr) |
HN (1) | HN1998000159A (fr) |
HR (1) | HRP980571A2 (fr) |
MA (1) | MA26558A1 (fr) |
PA (1) | PA8461701A1 (fr) |
PE (1) | PE122499A1 (fr) |
TN (1) | TNSN98194A1 (fr) |
WO (1) | WO1999021866A1 (fr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6710033B1 (en) | 1996-08-14 | 2004-03-23 | Vanderbilt University | Methods and treatment of multiple sclerosis |
US6890526B2 (en) | 1997-05-06 | 2005-05-10 | Vanderbilt University | Methods and reagents for the treatment of multiple sclerosis |
AP9801420A0 (en) * | 1998-01-02 | 1998-12-31 | Pfizer Prod Inc | Novel macrolides. |
WO1999062920A1 (fr) * | 1998-06-03 | 1999-12-09 | Pfizer Products Inc. | Derives 3-keto tricycliques de 6-o-methylerythromycine |
EP1298138B1 (fr) * | 1998-12-10 | 2006-11-02 | Pfizer Products Inc. | Dérivés anitiobiotiques de Carbamate et de Carbazate Kètolides |
DE69933897T2 (de) | 1998-12-10 | 2007-03-15 | Pfizer Products Inc., Groton | Carbamat- und Carbazatketolid-Antibiotika |
TR200102128T2 (tr) | 1999-01-27 | 2001-12-21 | Pfizer Products Inc. | Ketolid antibiyotikler |
WO2000071557A1 (fr) * | 1999-05-24 | 2000-11-30 | Pfizer Products Inc. | Derives de 13-methyl-erythromycine |
ID27331A (id) * | 1999-09-29 | 2001-03-29 | Pfizer Prod Inc | Pembuatan antibiotik-antibiotik ketolida karbamat |
US6498146B1 (en) * | 1999-10-28 | 2002-12-24 | Pfizer Inc | Erythromycin derivatives |
EP1146051A3 (fr) * | 2000-04-10 | 2001-10-31 | Pfizer Products Inc. | Dérivées de l' érythromycine A |
US20020115621A1 (en) * | 2000-08-07 | 2002-08-22 | Wei-Gu Su | Macrolide antibiotics |
US20070003508A1 (en) * | 2005-07-01 | 2007-01-04 | Wooley Richard E | Methods and compositions for promoting wound healing |
US20040208842A1 (en) * | 2001-09-18 | 2004-10-21 | Ritchie Branson W. | Antimicrobial cleansing compositions and methods of use |
US20040151765A1 (en) * | 2001-09-18 | 2004-08-05 | Ritchie Branson W. | Methods and compositions for wound management |
EP1638549A4 (fr) | 2003-03-10 | 2011-06-15 | Optimer Pharmaceuticals Inc | Nouveaux agents antibacteriens |
WO2005091967A2 (fr) * | 2004-03-03 | 2005-10-06 | University Of Georgia Research Foundation, Inc. | Procedes et compositions destines au traitement ophtalmique d'infections fongiques et bacteriennes |
UA85937C2 (uk) * | 2004-12-21 | 2009-03-10 | Пфайзер Продактс Інк. | Макроліди |
US9453042B2 (en) | 2007-10-25 | 2016-09-27 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
AU2009308182B2 (en) | 2008-10-24 | 2016-05-19 | Cempra Pharmaceuticals, Inc. | Biodefenses using triazole-containing macrolides |
US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
EP2475253B1 (fr) | 2009-09-10 | 2016-10-26 | Cempra Pharmaceuticals, Inc. | Méthodes de traitement du paludisme, de la tuberculose et des maladies à complexe mycobacterium avium (mac) |
CA2793884C (fr) | 2010-03-22 | 2019-09-10 | Cempra Pharmaceuticals, Inc. | Formes cristallines d'un macrolide et leurs utilisations |
DK2571506T3 (en) | 2010-05-20 | 2017-08-28 | Cempra Pharmaceuticals Inc | PROCEDURES FOR THE MANUFACTURE OF MACROLIDES AND KETOLIDES AND INTERMEDIATES |
KR20130120458A (ko) | 2010-09-10 | 2013-11-04 | 셈프라 파마슈티컬스, 인크. | 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드 |
US10188674B2 (en) | 2012-03-27 | 2019-01-29 | Cempra Pharmaceuticals, Inc. | Parenteral formulations for administering macrolide antibiotics |
CA2905975A1 (fr) | 2013-03-14 | 2014-09-25 | Cempra Pharmaceuticals, Inc. | Procedes pour traiter des maladies respiratoires et formulations pour la mise en oeuvre de ceux-ci |
CN105188712A (zh) | 2013-03-15 | 2015-12-23 | 森普拉制药公司 | 用于制备大环内酯抗菌剂的收敛方法 |
MX2015014026A (es) | 2013-04-04 | 2016-08-03 | Harvard College | Macrolidos y metodos para su preparacion y uso. |
CN106998685A (zh) | 2014-10-08 | 2017-08-01 | 哈佛大学的校长及成员们 | 14‑元酮内酯及其制备和使用方法 |
WO2016154591A1 (fr) | 2015-03-25 | 2016-09-29 | President And Fellows Of Harvard College | Macrolides à sucres modifiés de type désosamine et utilisations de ceux-ci |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL114589A (en) * | 1990-11-21 | 1999-12-22 | Roussel Uclaf | Intermediates for the preparation of the history of erythromycin |
US6060234A (en) * | 1991-01-17 | 2000-05-09 | Abbott Laboratories | Polyketide derivatives and recombinant methods for making same |
AU661585B2 (en) * | 1992-04-22 | 1995-07-27 | Taisho Pharmaceutical Co., Ltd. | 5-0-desosaminylerythronolide A derivative |
WO1998051696A1 (fr) * | 1997-05-09 | 1998-11-19 | Pfizer Products Inc. | Derives d'erythromycine |
WO1998056800A1 (fr) * | 1997-06-11 | 1998-12-17 | Pfizer Products Inc. | Derives de 9-oxime erythromycine |
-
1998
- 1998-10-08 HN HN1998000159A patent/HN1998000159A/es unknown
- 1998-10-09 US US09/402,338 patent/US6159945A/en not_active Expired - Fee Related
- 1998-10-09 WO PCT/IB1998/001578 patent/WO1999021866A1/fr active Application Filing
- 1998-10-09 AU AU92776/98A patent/AU9277698A/en not_active Abandoned
- 1998-10-16 PA PA19988461701A patent/PA8461701A1/es unknown
- 1998-10-22 PE PE1998000993A patent/PE122499A1/es not_active Application Discontinuation
- 1998-10-23 GT GT199800163A patent/GT199800163A/es unknown
- 1998-10-26 TN TNTNSN98194A patent/TNSN98194A1/fr unknown
- 1998-10-26 MA MA25314A patent/MA26558A1/fr unknown
- 1998-10-27 AR ARP980105379A patent/AR017177A1/es not_active Application Discontinuation
- 1998-10-29 CO CO98063687A patent/CO4810375A1/es unknown
- 1998-10-29 HR HR60/063,676A patent/HRP980571A2/hr not_active Application Discontinuation
- 1998-10-29 AP APAP/P/1998/001378A patent/AP9801378A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
AP9801378A0 (en) | 2000-04-29 |
PE122499A1 (es) | 1999-12-02 |
PA8461701A1 (es) | 2000-05-24 |
GT199800163A (es) | 2000-04-15 |
AU9277698A (en) | 1999-05-17 |
WO1999021866A1 (fr) | 1999-05-06 |
TNSN98194A1 (fr) | 2005-03-15 |
AR017177A1 (es) | 2001-08-22 |
HRP980571A2 (en) | 1999-08-31 |
US6159945A (en) | 2000-12-12 |
HN1998000159A (es) | 1999-02-09 |
CO4810375A1 (es) | 1999-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA26558A1 (fr) | Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
MA26472A1 (fr) | Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
MA26424A1 (fr) | Derives de 6-phenylpyridyl-2-amine, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
MA26680A1 (fr) | Derives de quinoleine-2-one a substituant alcynyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26686A1 (fr) | Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26468A1 (fr) | Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26414A1 (fr) | Derives de quinoleine et de quinazoline nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant. | |
MA26479A1 (fr) | Derives de nicotinamide, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26499A1 (fr) | Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant . | |
MA26433A1 (fr) | Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant | |
FR2780057B1 (fr) | Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26505A1 (fr) | Derives de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26438A1 (fr) | Derives 6,5-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
MA26432A1 (fr) | Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
MA26471A1 (fr) | Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
MA26425A1 (fr) | Derives de lactames, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26465A1 (fr) | Derives de quinoleine et derives de quinazoline nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26687A1 (fr) | 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26614A1 (fr) | Bicyclo [2.2.1] heptanes nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
MA26490A1 (fr) | Derives de tetrahydroisoquinoleine nouveaux, procedes pour leur preparation et compositions pharmaceutiques les contenant. | |
MA26740A1 (fr) | Derives de 13-methyl-erythromycine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26508A1 (fr) | Formulations pharmaceutiques contenant du variconazole, et procede pour leur preparation. | |
FR2735777B1 (fr) | Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant | |
MA26559A1 (fr) | Derives de d-proline, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation | |
MA26624A1 (fr) | Derives de quinazolinamines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant |